Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Borgia

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Dermatology|November 30, 2000
Elephantiasis nostras verrucosaM Vaccaro, F Borgia, F Guarneri, et al.
The British Journal of Dermatology|March 25, 2005
Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trialP Aragona, S P Cannavò, F Borgia, et al.
European Journal of Dermatology : EJD|July 15, 2000
Guess what? Trichlorhinophalangeal syndrome type IM Vaccaro, S P Cannavo, F Borgia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2006
Confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl: two distinct pathologies with a common pathogenetic pathway or a unique entity dependent on insulin resistance?S P Cannavò, C Guarneri, F Borgia, et al.
The British Journal of Dermatology|September 6, 2000
Photodistributed telangiectasia following use of cefotaximeF Borgia, M Vaccaro, F Guarneri, et al.
Dermatology (Basel, Switzerland)|October 5, 2001
Bullous pemphigoid following use of sulphasalazine for ulcerative colitis: drug-induced eruption or true association?M Vaccaro, D D'Amico, F Borgia, et al.
Current Medicinal Chemistry|March 12, 2009
Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infectionI Gentile, C Viola, F Borgia, et al.
Dermatology (Basel, Switzerland)|February 20, 2003
Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled studyS P Cannavò, F Guarneri, M Vaccaro, et al.
The British Journal of Dermatology|February 13, 2001
Dermatomyositis associated with IgG myelomaF Borgia, M Vaccaró, F Guarneri, et al.
Current Medicinal Chemistry|July 16, 2013
A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvirI Gentile, F Borgia, A R Buonomo, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Dermatology|November 30, 2000
Elephantiasis nostras verrucosaM Vaccaro, F Borgia, F Guarneri, et al.
The British Journal of Dermatology|March 25, 2005
Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trialP Aragona, S P Cannavò, F Borgia, et al.
European Journal of Dermatology : EJD|July 15, 2000
Guess what? Trichlorhinophalangeal syndrome type IM Vaccaro, S P Cannavo, F Borgia, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2006
Confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl: two distinct pathologies with a common pathogenetic pathway or a unique entity dependent on insulin resistance?S P Cannavò, C Guarneri, F Borgia, et al.
The British Journal of Dermatology|September 6, 2000
Photodistributed telangiectasia following use of cefotaximeF Borgia, M Vaccaro, F Guarneri, et al.
Dermatology (Basel, Switzerland)|October 5, 2001
Bullous pemphigoid following use of sulphasalazine for ulcerative colitis: drug-induced eruption or true association?M Vaccaro, D D'Amico, F Borgia, et al.
Current Medicinal Chemistry|March 12, 2009
Telaprevir: a promising protease inhibitor for the treatment of hepatitis C virus infectionI Gentile, C Viola, F Borgia, et al.
Dermatology (Basel, Switzerland)|February 20, 2003
Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled studyS P Cannavò, F Guarneri, M Vaccaro, et al.
The British Journal of Dermatology|February 13, 2001
Dermatomyositis associated with IgG myelomaF Borgia, M Vaccaró, F Guarneri, et al.
Current Medicinal Chemistry|July 16, 2013
A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvirI Gentile, F Borgia, A R Buonomo, et al.
Pageof 5